Claims: in drug dosage

1 claims
Narrow claims Pick any combination. Press Enter to apply typed text.
Clear filters
Speaker
Target
Topic
Certainty
Claim text
Date range
09 Sep 2025
Patients are prescribed higher dosages of GLP-1 drugs to maximize insurance reimbursement rates rather than for optimal patient health.

The reason that you're seeing side effects, the reason you're seeing this cascade effect of issues is because they are not treating patients with the most efficacious dose for that patient. They're treating patients with a dosage that reimburses the highest reimbursement rate on the insurance formulary. And I can prove this. They are overdosing people under, like literally, they're not taking the time to do the consult to educate the patient on diet, lifestyle, and nutrition. There is zero doubt that GLP1s are overutilized in America. There's zero doubt that they should not be a frontline defense. There is zero doubt that they don't come with some sort of risk factors. But most of those risk factors are found in higher dosages. So why would you start a patient on a higher dosage? Why would you rapidly titrate them up to a higher dosage where you're causing catastrophic muscle loss? It's because it reimburses more. It's not because it's what's better for the patient.